Cartesian Growth Corporation (GLBLU): Price and Financial Metrics

Cartesian Growth Corporation (GLBLU): $11.10

0.41 (-3.56%)

POWR Rating

Component Grades








GLBLU Price/Volume Stats

Current price $11.10 52-week high $27.14
Prev. close $11.51 52-week low $8.60
Day low $10.15 Volume 4,400
Day high $11.60 Avg. volume 0
50-day MA $10.06 Dividend yield N/A
200-day MA $10.04 Market Cap N/A

GLBLU Stock Price Chart Interactive Chart >

Cartesian Growth Corporation (GLBLU) Company Bio

Cartesian Growth Corporation operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.

GLBLU Latest News Stream

Event/Time News Detail
Loading, please wait...

GLBLU Latest Social Stream

Loading social stream, please wait...

View Full GLBLU Social Stream

Latest GLBLU News From Around the Web

Below are the latest news stories about Cartesian Growth Corp that investors may wish to consider to help them evaluate GLBLU as an investment opportunity.

Cartesian Growth Corporation Announces Closing of $345 Million Initial Public Offering

New York, NY, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Cartesian Growth Corporation (the “Company”) announced today the closing of its initial public offering of 34,500,000 units, including 4,500,000 units pursuant to the exercise of the underwriters’ over-allotment option. The offering was priced at $10.00 per unit generating total gross proceeds of $345,000,000. The Company’s sponsor is an affiliate of Cartesian Capital Group, LLC, a global private equity firm specializing in providing growth capital to transnational businesses. The units are listed on the Nasdaq Capital Market and trade under the ticker symbol “GLBLU.” Each unit consists of one Class A ordinary share of the Company and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class ...

Yahoo | February 26, 2021

Read More 'GLBLU' Stories Here

GLBLU Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year 11.45%
5-year N/A
2023 0.00%
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!